首页|An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral

An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral

扫码查看

Miao Mei、Maria_Antonietta Impagnatiello、Jun Jiao、Ulrich Reiser、Ulrike Tontsch-Grunt、Ju Zhang、Paul Nicklin、Bingke Yu、Yu Wang、Yuan He、Xu Tan

展开 >

Tsinghua-Peking Center for Life Sciences,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology,School of Pharmaceutical Sciences,Tsinghua University,Beijing 100084,China

Chinese Institutes for Medical Research,Beijing 100069,China

Boehringer Ingelheim RCV GmbH & Co KG,Vienna,Austria

College of Life Sciences and Oceanography,Shenzhen University,Shenzhen 518060,China

Research Beyond Borders,Boehringer Ingelheim,Biberach an der Riss,Germany

Research Beyond Borders,Boehringer Ingelheim,Shanghai 200120,China

展开 >

State Key Research Development Program of China to X.TState Key Research Development Program of China to X.TSpring Breeze Fund of Tsinghua University and funding from Boehringer Ingelheim InternationalNational Natural Science Foundation of China to M.Mfellowship of China Postdoctoral Science Foundationpostdoctoral fellowships from Tsinghua-Peking Life Center

2022YFE01022002021YFC2300200321001072021M691807

2024

蛋白质与细胞

蛋白质与细胞

CSTPCD
影响因子:0.645
ISSN:
年,卷(期):2024.15(1)
  • 14